Profile image
Story Views

Last Hour:
Last 24 Hours:

Gout Therapeutics Market Key Vendors (Companies) Global Analysis and Forecast to 2020

Friday, November 4, 2016 1:42
% of readers think this story is Fact. Add your two cents. adds a new research report Global Gout Therapeutics Market 2016-2020. This report covers the present scenario and the growth prospects of the global gout therapeutics market for 2016-2020. To calculate the market size, the report considers the revenue generated from the sales of branded, generic, and off-label drugs used for the treatment of gout and the revenues to be generated from the sales of drugs that are expected to be launched into the market along with the decline in revenues from the patent expiries of the marketed drugs.

This analyst forecast the global gout therapeutics market to grow at a CAGR of 17.16% during the period 2016-2020.

Complete report available @

Gout is one type of arthritis, which is caused by the high levels of uric acid in the blood. The main symptoms of gout are sudden attack of burning pain, swelling in a joint, and stiffness, usually in toe. If it is not treated, over time, it can harm tendons, joints, and other tissues. NSAIDs and urate-lowering agents are preferred treatment options for gout.

The report, Global Gout Therapeutics Market 2016-2020, has been prepared based on an in-depth market analysis with inputs from industry experts. This report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

For More Information Inquire at

Key vendors

  • AstraZeneca
  • Horizon Pharma
  • Takeda Pharmaceuticals

Other prominent vendors

  • Ablynx
  • Alder Biopharmaceuticals
  • Antares Pharma
  • Astellas Pharma
  • Boehringer Ingelheim
  • Can-Fite BioPharma
  • Celgene
  • Celltrion
  • ChemoCentryx
  • CymaBay Therapeutics
  • Eisai
  • Eli Lilly
  • Gilead Sciences
  • GlaxoSmithKline
  • Incyte
  • Ironwood Pharmaceuticals
  • JW Pharmaceutical
  • KaloBios Pharmaceuticals
  • Lexicon Pharmaceuticals
  • LG Life Sciences
  • Merck
  • Morphotek
  • Novartis
  • Novo Nordisk
  • Regeneron Pharmaceuticals
  • Sandoz
  • Sanofi
  • Santarus
  • Selecta Biosciences
  • Teijin Pharma
  • UCB
  • Vertex Pharmaceuticals.

Market driver

  • Introduction of novel urate-lowering agents
  • For a full, detailed list, view our report

Market challenge

  • Low physician and patient awareness
  • For a full, detailed list, view our report

Market trend

  • Focus on regenerative medicines
  • For a full, detailed list, view our report

Purchase Report @

About Us: is your single source for all market research needs. Our database includes 500,000+ market research reports from over 100+ leading global publishers & in-depth market research studies of over 5000 micro markets. With comprehensive information about the publishers and the industries for which they publish market research reports, we help you in your purchase decision by mapping your information needs with our huge collection of reports.

We encourage you to Share our Reports, Analyses, Breaking News and Videos. Simply Click your Favorite Social Media Button and Share.

Report abuse


Your Comments
Question   Razz  Sad   Evil  Exclaim  Smile  Redface  Biggrin  Surprised  Eek   Confused   Cool  LOL   Mad   Twisted  Rolleyes   Wink  Idea  Arrow  Neutral  Cry   Mr. Green

Top Stories
Recent Stories



Top Global


Top Alternative




Email this story
Email this story

If you really want to ban this commenter, please write down the reason:

If you really want to disable all recommended stories, click on OK button. After that, you will be redirect to your options page.